Catalog No.
RHA92901
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IHC: 1:100-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000
Target
OGA, Protein O-GlcNAcase, Meningioma-expressed antigen 5, Beta-N-acetylhexosaminidase, HEXC, N-acetyl-beta-glucosaminidase, KIAA0679, Nuclear cytoplasmic O-GlcNAcase and acetyltransferase, MEA5, MGEA5, Beta-hexosaminidase, NCOAT, Beta-N-acetylglucosaminidase, N-acetyl-beta-D-glucosaminidase
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O60502
Applications
IHC, IP, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1E63
Expression of O-GlcNAcylation in pulp tissue and dental pulp stem cells of healthy dental organs., PMID:40152124
HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC., PMID:39853458
A case of MSI-high pancreatic body-tail cancer successfully treated with radical resection after pembrolizumab., PMID:39402396
O-GlcNAcylation of ribosome-associated proteins is concomitant with translational reprogramming during proteotoxic stress., PMID:39395807
A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies., PMID:39381863
Systematic Evaluation of Affinity Enrichment Methods for O-GlcNAc Proteomics., PMID:39302247
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer., PMID:38964205
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE., PMID:38518549
Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge., PMID:38444344
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis., PMID:38184565
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study., PMID:37940383
Human schistosomiasis in Nigeria: present status, diagnosis, chemotherapy, and herbal medicines., PMID:37851179
Malocclusion impairs cognitive behavior via AgRP signaling in adolescent mice., PMID:37168929
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study., PMID:36881202
A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization., PMID:36855630
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers., PMID:36642483
Ac34FGlcNAz is an effective metabolic chemical reporter for O-GlcNAcylated proteins with decreased S-glyco-modification., PMID:36610251
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis., PMID:36446578
Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient-level placebo (Standard-of-Care) data to enable model-informed drug development., PMID:36350330
IgG4-related lung disease with multifocal pulmonary consolidations near the pleura: A case report., PMID:36042602
Dry preserved multilayered fibroblast cell sheets are a new manageable tool for regenerative medicine to promote wound healing., PMID:35869108
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease., PMID:35618441
CD44 is critical for the enhancing effect of hyaluronan in allergen-specific sublingual immunotherapy in a murine model of chronic asthma., PMID:35429379
Vaginal delivery after improvement in COVID-19 by monoclonal antibody treatment: A case report and literature review., PMID:35288022
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial., PMID:34800399
The Metabolic Chemical Reporter Ac46AzGal Could Incorporate Intracellular Protein Modification in the Form of UDP-6AzGlc Mediated by OGT and Enzymes in the Leloir Pathway., PMID:34712646
O-GlcNAcylation Quantification of Certain Protein by the Proximity Ligation Assay and Clostridium perfringen OGAD298N(CpOGAD298N)., PMID:34105348
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer., PMID:33865813
New Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations., PMID:35822169
Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase., PMID:33686291
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome., PMID:33258073
An unusual but unmissable link between summer-type hypersensitivity pneumonitis and asthma in an old house., PMID:32695568
Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases., PMID:32514165
Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience., PMID:32385734
O-GlcNAcylation of light chain serine 12 mediates rituximab production doubled by thiamet G., PMID:31980903
Comparison of hepatitis B vaccine efficacy in Japanese students: a retrospective study., PMID:31878867
Thoracoscopic Findings in IgG4-related Pleuritis., PMID:31554752
Loss of nivolumab binding to T cell PD-1 predicts relapse of Hodgkin lymphoma., PMID:31538325
A Chemical Genetic Method for Monitoring Genome-Wide Dynamics of O-GlcNAc Turnover on Chromatin-Associated Proteins., PMID:31041386
Ac4GlcNAcF3, an OGT-tolerated but OGA-resistant regulator for O-GlcNAcylation., PMID:30713024
Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety., PMID:30693278
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study., PMID:30510079
A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement., PMID:30383634
Detecting and Imaging O-GlcNAc Sites Using Glycosyltransferases: A Systematic Approach to Study O-GlcNAc., PMID:30100348
[An eye for an eye? Lack of consensus in off-label use of medications leads to major regional differences in medical costs for the treatment of wet AMD in Sweden]., PMID:29292948
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency., PMID:28786256
Characterization of tools to detect and enrich human and mouse O-GlcNAcase., PMID:28595377
The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies., PMID:28461123
Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress., PMID:28232487
The Nuts and Bolts of Immunoglobulin Treatment for Antibody Deficiency., PMID:27836057
For research use only. Not for human or drug use.
